1. Introduction {#j_med-2018-0062_s_001}
===============

Human Immunodeficiency Virus-1 (HIV-1)/Acquired Immunodeficiency Syndrome (AIDS), the world major infectious killer remains one of the most important public health challenges in the world. It was estimated that about 36.7 (34.0-39.8) million people were living with HIV in 2016, and 1.8 million people have died from HIV/AIDS every year. Therefore, HIV prevalence can be considered as the greatest issue in contemporary society, including economic and health crisis \[[@j_med-2018-0062_ref_001]\]. However, many basic questions about the HIV-1 infection pathogenesis have not been answered. Several studies demonstrated that they have a significant difference in susceptibility and progression of HIV-1 infection \[[@j_med-2018-0062_ref_002], [@j_med-2018-0062_ref_003], [@j_med-2018-0062_ref_004]\]. Host genetic diversity has an important role in either disease susceptibility or resistance \[[@j_med-2018-0062_ref_004], [@j_med-2018-0062_ref_005]\]. However, the positive role of different genes in HIV/AIDS progression has still remained controversial \[[@j_med-2018-0062_ref_006], [@j_med-2018-0062_ref_007]\].

Its chemokines and their natural receptors act a key part in HIV-1 binding and entry \[[@j_med-2018-0062_ref_008]\]. Chemokine receptors act on CD4 as a relevant receptor for HIV-1 to regulate the first step in the entry of HIV-1 virus. CCR5, a chemokine receptor of gene product, is expressed on macrophages, monocytes, T and dendritic cells. This is a specific receptor for the CC ligand 3 (CCL3), CCL4, and CCL5 chemokine and a key part in the transferring of immune cells to inflammatory sites \[[@j_med-2018-0062_ref_009]\]. The CCR5Δ32 variant is characterized by a 32 base-pair (bp) deletion of the CCR5's gene coding region; the deletion of CCR5-delta32 was initially discovered and gained the greatest interest in the relation to infection with the HIV-1. This lack of homozygosity is associated with preventing the risk of HIV-1 infection \[[@j_med-2018-0062_ref_010]\]. Liu et al performed a meta-analysis and demonstrated that there was no statistical correlation between the CCR5-delta32 polymorphism and the risk of HIV-1 infection. For adults, the CCR5-delta32 polymorphism was investigated for their association with the risk of HIV-1 infection, but the results from the previous published researches remains conflicting and inconclusive \[[@j_med-2018-0062_ref_011], [@j_med-2018-0062_ref_012], [@j_med-2018-0062_ref_013], [@j_med-2018-0062_ref_014], [@j_med-2018-0062_ref_015], [@j_med-2018-0062_ref_016], [@j_med-2018-0062_ref_017], [@j_med-2018-0062_ref_018], [@j_med-2018-0062_ref_019], [@j_med-2018-0062_ref_020], [@j_med-2018-0062_ref_021], [@j_med-2018-0062_ref_022], [@j_med-2018-0062_ref_023], [@j_med-2018-0062_ref_024], [@j_med-2018-0062_ref_025], [@j_med-2018-0062_ref_026], [@j_med-2018-0062_ref_027], [@j_med-2018-0062_ref_028], [@j_med-2018-0062_ref_029], [@j_med-2018-0062_ref_030], [@j_med-2018-0062_ref_031], [@j_med-2018-0062_ref_032], [@j_med-2018-0062_ref_033], [@j_med-2018-0062_ref_034]\]. Thus, we conducted the present meta-analysis by pooling all available publications to evaluate the possible role of CCR5-delta32 polymorphism and HIV-1 infection susceptibility.

2. Methods {#j_med-2018-0062_s_002}
==========

2.1. Literature search {#j_med-2018-0062_s_002_s_001}
----------------------

From inception to April 2018, we conducted electronic searches using the terms "CCR5-delta32", "polymorphism\*" or "variant\*" or "mutation", "HIV" through PubMed, EMBASE, China National Knowledge Internet (CNKI), WanFang, and the Cochrane Library for relevant studies. No language restriction was applied.

2.2. Selection criteria {#j_med-2018-0062_s_002_s_002}
-----------------------

Articles must satisfy the following criteria: (a) evaluated the relation between CCR5-delta32 and the risk of HIV-1 infection; (b) case-control studies on human beings, no language restriction was applied; (c) sufficient data to evaluate the odds ratios (ORs) and 95% credible interval (CI), and *P* values; and (e) genotype distribution in controls must be in Hardy-Weinberg equilibrium (HWE) (*P* \< 0.001). Review articles, conference abstracts, case reports and insufficient data to evaluate ORs and 95%CI were excluded.

2.3. Data extraction {#j_med-2018-0062_s_002_s_003}
--------------------

Data extraction was done by two authors through a standardized form independently, such as first author, year of publication, country, ethnicity, source of the controls, genotype distribution of cases and controls, and *P* values for HWE in controls. Discrepancies were settled by discussion, with disagreements resolved by consensus.

2.4. Statistical analyses {#j_med-2018-0062_s_002_s_004}
-------------------------

The pooled odds ratio (ORs) along with 95% credible interval (95%CI) was utilized to access the strength of relation between the CCR5-delta32 and HIV-1 infection risk. We also conducted stratified analyses by ethnicity and sources of controls. The *I*2 and Cochran's *Q*-test statistics were used to quantify the statistical heterogeneity, and the random-effect model was conducted if heterogeneity was significant (*P \<* 0.05) \[[@j_med-2018-0062_ref_035]\]; otherwise, the fixed-effect model was conducted\[[@j_med-2018-0062_ref_036]\]; *P* \< 0.05 was considered as a significant difference in the value between the two groups. Sensitivity analysis was performed by sequentially excluding studies to assess the stability of the pooled results. Begg's funnel plot and the Egger's tests was performed to evaluate the potential publication bias of the researches (*P* \< 0.05 was considered significant) \[[@j_med-2018-0062_ref_037], [@j_med-2018-0062_ref_038]\]. The present meta-analysis was carried out by STATA 12.0 (Stata Corp LP, College Station, TX, USA).

3. Results {#j_med-2018-0062_s_003}
==========

3.1. Characteristics of included studies {#j_med-2018-0062_s_003_s_001}
----------------------------------------

In this meta-analysis, the selection of eligible researches included is shown in [Figure 1](#j_med-2018-0062_fig_001){ref-type="fig"}, 517 potentially relevant researches were initially obtained from the PubMed, EMBASE, China National Knowledge Internet (CNKI), WanFang, and the Cochrane Library. After the exclusion of irrelevant studies, a total of 24 published researches were identified to be eligible for the current study. The flow diagram describing selected studies inclusion or exclusion is in [Figure 1](#j_med-2018-0062_fig_001){ref-type="fig"}. The baseline features of the selected researches are recorded in [Table 1](#j_med-2018-0062_tab_001){ref-type="table"}.

![Flow diagram of the publication selection process.](med-13-467-g001){#j_med-2018-0062_fig_001}

###### 

Main characteristics of studies included in the meta-analysis

  Author        Year   Country      Ethnicity   Genotyping methods   Sample size Case   Control   HWE
  ------------- ------ ------------ ----------- -------------------- ------------------ --------- --------
  Tan           2010   China        Asians      PCR                  251                238       0.1899
  Desgranges    2001   Santiago     Mixed       PCR                  63                 62        0.8452
  Rathore       2008   India        Asians      PCR                  190                370       0.8656
  Xu            2009   China        Asians      PCR-RFLP             78                 70        0.9035
  Shrestha      2006   American     Caucasian   PCR                  266                532       0.7247
  Liu           2004   American     Caucasian   PCR                  316                519       0.8926
  Veloso        2010   Spanish      Caucasian   PCR-RFLP             184                236       0.3255
  Munerato      2003   Brazilian    Caucasian   PCR                  183                115       0.4544
  Adojaan       2007   Estonia      Caucasian   PCR                  3000               488       0.0026
  Alvarez       1998   Spanish      Caucasian   PCR                  150                250       0.6120
  Zimmerman     1997   American     Caucasian   PCR                  745                1096      0.8830
  Mandl         1998   Austria      Caucasian   PCR                  225                451       0.4286
  Wang          2008   China        Asians      PCR-RFLP             104                155       0.9863
  Tiensiwakul   2004   Thailand     Asians      PCR-RFLP             116                622       0.9610
  Rigato        2008   Brazil       Caucasian   PCR-RFLP             200                82        0.5990
  Roman         2014   Luxembourg   Mixed       PCR-RFLP             288                155       0.7356
  Wang          2003   China        Asians      PCR-RFLP             330                474       0.9817
  Deng          2004   China        Asians      PCR                  88                 119       0.9263
  Balotta       1997   Italy        Caucasian   PCR                  152                122       0.3977
  Ellwanger     2018   Brazil       Caucasian   PCR                  300                274       0.4210
  Heydarifard   2017   Iran         Asians      PCR                  140                300       0.7920
  Zapata        2013   Colombia     Mixed       PCR                  57                 112       0.8091
  Li            2003   China        Asian       PCR-RFLP             24                 46        0.9406
  Rugeles       2002   Colombia     Mixed       PCR                  36                 50        0.0381

HWE, Hardy-Weinberg equilibrium; AA, CCR5 homozygotes; AB, CCR5-delta32 heterozygotes; BB, delta32 homozygotes.

3.2. Meta-analysis results {#j_med-2018-0062_s_003_s_002}
--------------------------

A total of 24 case-control studies were included in the present work to estimate the relation between the CCR5-delta32 polymorphism and the HIV-1 infection risk. To sum up, pooled risk evaluations shows a statistically significant relation between the CCR5-delta32 polymorphism and increased HIV-1 infection risk in the CCR5-delta32 heterozygotes genotype (OR=1.16, 95%CI=1.02-1.32, P=0.024) for healthy controls ([Figure 2](#j_med-2018-0062_fig_002){ref-type="fig"} and [Table 3](#j_med-2018-0062_tab_003){ref-type="table"}). Meanwhile, we found the risk of HIV-1 infection was significantly reduced in the delta32 homozygous genotype (OR=0.25, 95%CI=0.09-0.68, P=0.006) for healthy controls ([Table 3](#j_med-2018-0062_tab_003){ref-type="table"}). When we conducted stratified analysis by sources of control, we also detected a significantly risk decline of HIV-1 infection in the delta32 allele carriers (OR=0.71, 95%CI=0.54-0.94, P=0.015) among exposed uninfected populations ([Figure 3](#j_med-2018-0062_fig_003){ref-type="fig"} and [Table 3](#j_med-2018-0062_tab_003){ref-type="table"}). We also performed the stratified analysis by ethnicity, there was significant association in Caucasian with delta32 allele carrier genotype.

![Forest plots demonstrating the association between CCR5-delta32 polymorphism and HIV-1 infection susceptibility in the CCR5-delta32 heterozygote model.](med-13-467-g002){#j_med-2018-0062_fig_002}

![Forest plots demonstrating the association between CCR5-delta32 polymorphism and HIV-1 infection susceptibility in the delta32 homozygote model.](med-13-467-g003){#j_med-2018-0062_fig_003}

###### 

The distribution of CCR5-delta32 genotype of included studies.

  Author        Ethnicity   HIV-1 infected       Healthy Controls         Exposed uninfected                                 
  ------------- ----------- ---------------- --- ------------------ ----- -------------------- ----- -- ----- --- ----- ---- ---
  Tan           Asians      226                                     24    1                    222      15    1              
  Desgranges    Mixed       60                                      3     0                    59       3     0              
  Rathore       Asians      190                                     0     0                    314      6     0   50    0    0
  Xu            Asians      74                                      4     0                    68       2     0              
  Shrestha      Caucasian   258                                     8     0                    516      16    0              
  Liu           Caucasian   261                                     55    0                    354      68    3   69    22   3
  Veloso        Caucasian   144                                     40    0                    174      26    0   31    5    0
  Munerato      Caucasian   162                                     21    0                    100      15    0              
  Adojaan       Caucasian   230                                     70    0                    371      117   0              
  Alvarez       Caucasian   138                                     12    0                    205      42    3              
  Zimmerman     Caucasian   601                                     144   0                    846      121   4   94    26   5
  Mandl         Caucasian   182                                     43    0                    367      78    6              
  Wang          Asians      104                                     0     0                    104      0     0   51    0    0
  Tiensiwakul   Asians      116                                     0     0                    432      0     0   190   0    0
  Rigato        Caucasian   185                                     15    0                    73       9     0              
  Roman         Mixed       226                                     62    0                    127      27    1              
  Wang          Asians      329                                     1     0                    473      1     0              
  Deng          Asians      88                                      0     0                    117      2     0              
  Balotta       Caucasian   136                                     15    1                    108      13    1              
  Ellwanger     Caucasian   265                                     35    0                    240      32    2              
  Heydarifard   Asians      139                                     1     0                    291      9     0              
  Zapata        Mixed       51                                      6     0                    107      5     0   63    7    0
  Li            Asian       23               1   0                                                                45    1    0
  Rugeles       Mixed       33               3   0                                                                47    2    1

AA, CCR5 homozygotes; AB, CCR5-delta32 heterozygotes; BB, delta32 homozygotes.

###### 

Meta-analysis of the association between CCR5-delta32 polymorphism and HIV-1 infection susceptibility

  Comparison     Subgroup      Studies   Heterogeneity test   Association test   Model             Publication bias       
  -------------- ------------- --------- -------------------- ------------------ ----------------- ------------------ --- -------
  B vs. A        Overall       24        0.037                39.4               1.08(0.96-1.22)   0.222              F   0.125
                 Mixed         3         0.000                0                  1.26(0.83-1.92)   0.277              R   
                 Caucasian     11        0.070                56.8               0.99(0.79-1.23)   0.918              R   
                 Asian         6         0.267                24.2               0.90(0.39-2.06)   0.803              R   
                 EUs           6         0.355                9.5                0.71(0.54-0.94)   0.015              F   
  AB vs. AA      Overall       20        0.035                39.8               1.16(1.02-1.32)   0.024              F   0.078
                 Mixed         3         0.564                0                  1.38(0.88-2.16)   0.157              R   
                 Caucasian     11        0.010                57.0               1.05(0.83-1.33)   0.665              R   
                 Asian         6         0.228                27.5               0.89(0.37-2.13)   0.791              R   
                 EUs           6         0.549                0                  0.91(0.66-1.25)   0.568              F   
  BB vs. AA      Overall       8         0.965                0                  0.25(0.09-0.68)   0.006              F   0.058
                 Caucasian     6         0.966                0                  0.22(0.07-0.69)   0.009              F   
                 EUs           3         0.274                22.8               0.06(0.01-0.32)   0.001              F   
  AB+BB vs. AA   Overall       20        0.028                41.3               1.12(0.99-1.28)   0.071              F   0.096
                 Mixed         3         0.541                0                  1.34(0.86-2.09)   0.196              R   
                 Caucasian     11        0.007                58.5               1.02(0.81-1.29)   0.871              R   
                 Asian         6         0.235                26.6               0.89(0.38-2.10)   0.791              R   
                 EUs Overall   6         0.441                0                  0.80(0.59-1.08)   0.141              F   
  BB vs. AA+AB   Caucasian     8         0.963                0                  0.25(0.09-0.67)   0.006              F   0.058
                 EUs           6         0.962                0                  0.21(0.07-0.68)   0.009              F   
                               3         0.292                18.8               0.06(0.01-0.32)   0.001              F   

OR, odds ratio; CI, confidence interval; F, fixed-effects model; R, random-effects model; EUs, exposed uninfected.

3.3. Sensitivity analysis and publication bias {#j_med-2018-0062_s_003_s_003}
----------------------------------------------

Sensitivity analysis was conducted by sequentially excluding individual studies to assess the impact of each study on the summarized findings. This revealed that the findings were statistically robust and credible (data not shown) ([Figure 4](#j_med-2018-0062_fig_004){ref-type="fig"}). Begg's and Egger's test ([Table 3](#j_med-2018-0062_tab_003){ref-type="table"}) was utilized to examine the potential bias of the publication \[[@j_med-2018-0062_ref_037], [@j_med-2018-0062_ref_038]\]. The shape of the funnel plot was symmetrical as shown in [Figure 5](#j_med-2018-0062_fig_005){ref-type="fig"} suggesting there was no obvious publication bias.

![Sensitivity analysis for the influences of CCR5-delta32 polymorphism and HIV-1 infection susceptibility under the allele model.](med-13-467-g004){#j_med-2018-0062_fig_004}

![Funnel plot of publication biases on the association between CCR5-delta32 polymorphism and HIV-1 infection susceptibility.](med-13-467-g005){#j_med-2018-0062_fig_005}

4. Discussion {#j_med-2018-0062_s_004}
=============

AIDS remains one of the biggest public health challenges of the world, as we all know, it is a complex infectious disease, including HIV-1 infection, host immune response, and gene-environment interactions. Several studies have already found that both viral genetics and host genetic factors are important determinants of HIV-1 infection \[[@j_med-2018-0062_ref_004], [@j_med-2018-0062_ref_005], [@j_med-2018-0062_ref_010]\]. Chemokines and chemokine receptors are critical for immune response in HIV-1 infection. Although many researches demonstrated the association between chemokine and chemokine receptor gene polymorphisms, and host's susceptibility to HIV-1 infection, the conclusions are still controversial \[[@j_med-2018-0062_ref_011], [@j_med-2018-0062_ref_012], [@j_med-2018-0062_ref_013]\].

Meta-analysis, a useful statistical tool through integrating and comparing the results of many related researches and taking into consideration of variations in characteristics that can affect overall estimate of the outcome of interest, which is used to evaluate the literature in both quantitative and qualitative ways. So it is especially worthy when previous researches could not provide significant differences among treatments because of sample sizes limitations, or when there is no consensus \[[@j_med-2018-0062_ref_039]\]. Despina et al. performed a meta-analysis and demonstrated that perinatal infection is not determined by heterozygosity for CCR5-delta32 in the children \[[@j_med-2018-0062_ref_040]\]. In addition, Liu et al. performed a meta-analysis suggested that no statistical relation was detected between the CCR5-delta32 polymorphism and HIV-1 infection risk in any genetic model \[[@j_med-2018-0062_ref_041]\].

Considering that many researches have produced conflicting results, we conducted the present meta-analysis involving 24 eligible researches with 4,786 cases and 6,283 controls. The present researches showed there is a significant relation between CCR5-delta32 polymorphism and the risk of HIV-1 infection in the total population. In CCR5-delta32 heterozygotes genetic model, we have detected a statistically significant increased susceptibility to HIV-1 infection (OR=1.16, 95%CI=1.02-1.32, P=0.024) for healthy control. Meanwhile, we have found significantly reduced the risk of HIV-1 infection in the delta32 homozygous genetic model (OR=0.25, 95%CI=0.09-0.68, P=0.006). In healthy subjects, CCR5-delta polymorphism may be protective effects against HIV-1 infection only in the delta32 homozygous individuals (OR=0.25, 95%CI=0.09-0.68, P=0.006). Stratified analysis by EU population, the results demonstrated that CCR5-delta32 polymorphism may be protect effects against HIV-1 infection susceptibility in the delta32 allele carriers (OR=0.71, 95%CI=0.54-0.94, P=0.015), which was in accordance with that in the healthy subjects. Meanwhile, we also conducted the stratified analyses by ethnicity, we have detected significant relation between the CCR5-delta32 polymorphism and HIV-1 infection susceptibility in Caucasian subjects.

There are several limitations in the current study. Firstly, suitable English or Chinese-language studies were only enrolled in current meta-analysis, which means related researches published in other languages may have been overlooked, which may also lead to selection bias. Secondly, the number as well as the sample size of some included studies was limited and the results should be interpreted with caution. Finally, the influences of other relevant components such as age, gender, life style as well as their interactions with CCR5-delta32 polymorphism on HIV-1 infection susceptibility were not analyzed due to the lack of original data.

5. Conclusion {#j_med-2018-0062_s_005}
=============

In conclusion, our findings indicated that the CCR5-delta32 homozygous genotype (delta32/delta32) confer possible protection against HIV-1 infection, especially in exposed uninfected population. However, this conclusion should be confirmed by multi-center and large-scale studies based on multiple ethnic groups.
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